BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11229596)

  • 1. Demonstration of estrogen receptors and of estrogen responsiveness in the HKT-1097 cell line derived from diethylstilbestrol-induced kidney tumors.
    Brohée R; Nonclercq D; Journé DN; Toubeau G; Falmagne P; Leclercq G; Heuson-Stiennon JA; Laurent G
    In Vitro Cell Dev Biol Anim; 2000; 36(10):640-9. PubMed ID: 11229596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptors in the diethylstilbestrol-induced kidney neoplasms of the Syrian golden hamster: correlation with histopathology and tumoral stages.
    Cortés-Vizcaíno V; Llombart-Bosch A
    Carcinogenesis; 1993 Jun; 14(6):1215-9. PubMed ID: 7685247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen responsiveness of IBEP-2, a new human cell line derived from breast carcinoma.
    Journé F; Body JJ; Leclercq G; Nonclercq D; Laurent G
    Breast Cancer Res Treat; 2004 Jul; 86(1):39-53. PubMed ID: 15218360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cell line established from diethylstilbestrol-induced renal tumors in Syrian hamsters.
    Laurent G; Nonclercq D; Journé F; Brohée R; Toubeau G; Falmagne P; Heuson-Stiennon JA
    In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):339-45. PubMed ID: 10476921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG; Johnson IE; DeSombre ER; Toth J; Hughes A
    Cancer Res; 1987 May; 47(10):2645-51. PubMed ID: 3552202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of estrogen carcinogenesis in the hamster kidney by ethinylestradiol: some unique properties of a synthetic estrogen.
    Li JJ; Hou X; Bentel J; Yazlovitskaya EM; Li SA
    Carcinogenesis; 1998 Mar; 19(3):471-7. PubMed ID: 9525282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward functional glycomics by localization of tissue lectins: immunohistochemical galectin fingerprinting during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.
    Saussez S; Nonclercq D; Laurent G; Wattiez R; André S; Kaltner H; Gabius HJ; Kiss R; Toubeau G
    Histochem Cell Biol; 2005 Jan; 123(1):29-41. PubMed ID: 15609042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol.
    Brandes LJ; Hermonat MW
    Cancer Res; 1983 Jun; 43(6):2831-5. PubMed ID: 6850594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney.
    Li JJ; Li SA; Klicka JK; Parsons JA; Lam LK
    Cancer Res; 1983 Nov; 43(11):5200-4. PubMed ID: 6616455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of stilbene estrogen-induced cell proliferation of renal epithelial cells through the modulation of insulin-like growth factor-I receptor expression.
    Chen CW; Oberley TD; Roy D
    Cancer Lett; 1996 Jul; 105(1):51-9. PubMed ID: 8689633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation of DNA in estrogen-induced and -dependent hamster kidney tumors.
    Lu LJ; Liehr JG; Sirbasku DA; Randerath E; Randerath K
    Carcinogenesis; 1988 Jun; 9(6):925-9. PubMed ID: 3370756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards functional glycomics by localization of binding sites for tissue lectins: lectin histochemical reactivity for galectins during diethylstilbestrol-induced kidney tumorigenesis in male Syrian hamster.
    Saussez S; Lorfevre F; Nonclercq D; Laurent G; André S; Journé F; Kiss R; Toubeau G; Gabius HJ
    Histochem Cell Biol; 2006 Jul; 126(1):57-69. PubMed ID: 16435123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exchange of bound estrogens and antiestrogens in MCF-7 cells: evidence for ligand-induced stable configurations of the estrogen receptor.
    El khissiin A; Leclercq G
    Steroids; 1998 Nov; 63(11):565-74. PubMed ID: 9830682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment.
    Seo HS; Journé F; Larsimont D; Sotiriou C; Leclercq G
    Steroids; 2003 Mar; 68(3):257-69. PubMed ID: 12628689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of estrogen structure on nuclear binding and progesterone receptor induction by the receptor complex.
    VanderKuur JA; Wiese T; Brooks SC
    Biochemistry; 1993 Jul; 32(27):7002-8. PubMed ID: 8334129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis.
    Debauve G; Nonclercq D; Ribaucour F; Wiedig M; Gerbaux C; Leo O; Laurent G; Journé F; Belayew A; Toubeau G
    Mol Cancer; 2006 Jun; 5():23. PubMed ID: 16762066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of transforming growth factor-alpha and its receptor in a model of DES-induced renal carcinogenesis in the Syrian hamster.
    Wattiez R; Nonclercq D; Journé F; Toubeau G; Zanen J; Falmagne P; Heuson-Stiennon JA
    Carcinogenesis; 1996 Aug; 17(8):1615-22. PubMed ID: 8761417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of diethylstilbestrol carcinogenicity as studied with the fluorinated analogue E-3',3",5',5"-tetrafluorodiethylstilbestrol.
    Liehr JG; Ballatore AM; McLachlan JA; Sirbasku DA
    Cancer Res; 1983 Jun; 43(6):2678-82. PubMed ID: 6850586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.